NewsDialy
Shareholders' equity, the number you get when you subtract a company's debts from the value of everything it owns, has a minimum floor on the Nasdaq exchange. (Nasdaq: INM) slipped below it.
Nasdaq's Listing Qualifications Department told the Vancouver-based drug developer on September 18, 2026 that its equity of $1,075,007, reported in its annual filing for the fiscal year ended June 30, 2026, fell short of the $2,500,000 minimum set by Nasdaq Listing Rule 5550(b)(1).
What pushed equity below the line The company pointed to costs tied to its planned merger with Mentari Therapeutics, Inc.
Transaction-related expenses from that agreement, dated May 19, 2026, landed on InMed's books before the deal closed.
Keep reading